Evolutionary Genomics, Inc. (OTCPK: FNAM)
Health Care · Biotechnology · US
$—
— today · — 1Y
Evolutionary Genomics, Inc. (OTCPK: FNAM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.33K and employs 2 people.
trading between 0.00 and 0.00.
Tweenvest scores Evolutionary Genomics, Inc. across four factors: quality 26/100, value 30/100. Its strongest factor is value.
FNAM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.33K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.35
- Dividend yield
- —
- Beta (5Y)
- -0.10
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.66M
- Employees
- 2
- Next earnings
- —
About Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
- ISIN
- US30051F1012
- Listed since
- Apr 8, 2011
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OncoVista Innovative Therapies, Inc.OTCPK: OVIT | $2.36K | $0.00 | — |
| Lipella Pharmaceuticals Inc.OTCPK: LIPO | $2.31K | $0.00 | -98.47% |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $0.00 | — |
| Affimed N.V.OTCPK: AFMD.Q | $1.64K | $0.00 | -50.00% |
| GlobeStar Therapeutics CorporationOTCPK: GSTC | $1.24K | $0.00 | — |
| Adhera Therapeutics, Inc.OTCPK: ATRX | $1.16K | $0.00 | — |
| EV Biologics, Inc.OTCPK: YECO | $1.02K | $0.00 | -66.67% |
| eFFECTOR Therapeutics, Inc.OTCPK: EFTR | $941.00 | $0.00 | -75.00% |
Figures last refreshed Oct 18, 2026.